FDA Approval Summary: Osimertinib for Adjuvant Treatment of Surgically Resected Non-Small Cell Lung Cancer, a Collaborative Project Orbis Review von Koch, Abigail L, Vellanki, Paz J, Drezner, Nicole, Li, Xiaoxue, Mishra-Kalyani, Pallavi S, Shen, Yuan Li, Xia, Huiming, Li, Yangbing, Liu, Jiang, Zirkelbach, Jeanne Fourie, Palazov, Elitza, Gamarian, Aleksandr, Choo, Qiuyi, Girčys, Arūnas, Rohr, Ulrich-Peter, Fesenko, Nataliya, Spillman, Dianne, Pazdur, Richard, Beaver, Julia A, Singh, Harpreet

Volltext

A decade comparison of regulatory decision patterns for oncology products to all other non-oncology products among Swissmedic, European Medicines Agency, and US Food and Drug Admin... von Rohr, Ulrich-P, Iovino, Mario, Rudofsky, Leonie, Li, Qiyu, Juritz, Stephanie, Gircys, Arunas, Wildner, Oliver, Bujar, Magda, Bolte, Claus, Dalla Torre di Sanguinetto, Simon, Wolfer, Anita

Volltext

Regulatory Challenges: Is a Surrogate End Point Instead of Overall Survival Enough for Regulatory Approval of (Neo)Adjuvant Cancer Treatment? The Swissmedic Perspective von Pavic, Matea, Wolfer, Anita, Li, Qiyu, Gircys, Arunas, Juritz, Stephanie, Wicki, Andreas, Cerny, Thomas, Rohr, Ulrich-Peter

Volltext

Regulatory Challenges: Is a Surrogate End Point Instead of Overall Survival Enough for Regulatory Approval of (Neo)Adjuvant Cancer Treatment? The Swissmedic Perspective von Pavic, Matea, Wolfer, Anita, Li, Qiyu, Gircys, Arunas, Juritz, Stephanie, Wicki, Andreas, Cerny, Thomas, Rohr, Ulrich-Peter

Volltext

Blood Pressure Estimation Accoording to Photoplethysmographic Signal Steepness von Gircys, Rolandas, Liutkevicius, Agnius, Vrubliauskas, Arunas, Kazanavicius, Egidijus

Volltext